Skip to main content

Advertisement

Table 3 Baseline characteristics of HCC patients with regular surveillance

From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

Characteristics Low risk group High risk group
Short interval Long interval P Short interval Long interval P
Patients 199 (75.7) 64 (24.3)   145 (79.7) 37 (20.3)  
Pre-TACE 22 (11.1) 11 (17.2) 0.284 71 (49.0) 12 (32.4) 0.106
Age (yrs.) 55.0 (17.5) 54.0 (19.5) 0.962 56.0 (14) 61.0 (21) 0.058
Male 177 (88.9) 61 (95.3) 0.206 135 (93.1) 35 (94.6) 1.000
Tumor number    1.000    0.971
 Singular 199 (100.0) 64 (100.0)   69 (47.6) 18 (48.6)  
 Multiple   76 (52.4) 19 (51.4)  
Tumor size       0.631
 ≤ 3 cm 199 (100.0) 64 (100.0)   34 (37.2) 16 (43.2)  
 > 3 cm   91 (62.8) 21 (56.8)  
Risk area 50 (25.1) 14 (21.9) 0.719 39 (26.9) 9 (24.3) 0.914
AFP ≥200 ng/ml 67 (33.7) 10 (15.6) 0.009 86 (59.3) 20 (54.1) 0.695
Hb (109/L) 143.0 (2.80) 145.5 (19.2) 0.331 142.0 (21.2) 142.0 (22.1) 0.367
PLT (109/L) 131.0 (96.0) 129.5 (95.9) 0.896 105.1 (85.0) 132.0 (98.0) 0.452
RBC (109/L) 4.5 (0.8) 4.8 (0.8) 0.013 4.6 (0.8) 4.5 (0.9) 0.556
WBC (109/L) 5.3 (2.5) 5.4 (2.5) 0.579 5.2 (2.5) 5.80 (0.9) 0.357
ALB (g/L) 41.9 (7.9) 42.5 (5.6) 0.671 41.2 (5.8) 40.3 (6.7) 0.804
ALT (U/L) 34.1 (23.4) 37.2 (29.5) 0.229 37.1 (29.1) 36.0 (25.3) 0.773
AST (U/L) 32.3 (20.0) 33.5 (20.0) 0.802 35.7 (22.3) 35.5 (28.6) 0.868
TBIL (μmol/L) 14.4 (9.0) 15.2 (6.8) 0.678 16.0 (11.8) 14.3 (5.2) 0.137
Child-Pugh grade    0.732    0.348
 A 191 (96.0) 44 (95.3)   138 (95.2) 44 (100.0)  
 B 8 (4.0) 3 (4.7)   7 (4.80) 0 (0.00)  
PT (seconds) 12.3 (1.7) 12.1 (1.6) 0.135 12.3 (1.8) 12.4 (1.8) 0.837
Viral hepatitis 184 (92.5) 59 (92.2) 1.000 137 (94.5) 34 (91.9) 0.838
Cirrhosis 159 (79.9) 51 (79.7) 1.000 125 (86.2) 26 (70.3) 0.040
  1. Abbreviations: TACE Transcatheter arterial chemoembolization, AFP alpha-fetoprotein, Hb Hemoglobin, PLT platelet, RBC red blood cell, WBC white blood cell, ALB albumin, ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, PT prothrombin time
  2. Values are presented as the median (IQR) or n (%)